Compare CMND & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMND | ULY |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.8M |
| IPO Year | N/A | N/A |
| Metric | CMND | ULY |
|---|---|---|
| Price | $1.18 | $2.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | ★ 449.2K | 401.4K |
| Earning Date | 03-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $127,932,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.05 | $1.74 |
| 52 Week High | $58.00 | $17.99 |
| Indicator | CMND | ULY |
|---|---|---|
| Relative Strength Index (RSI) | 28.84 | 44.98 |
| Support Level | $1.05 | $2.01 |
| Resistance Level | $2.31 | $2.32 |
| Average True Range (ATR) | 0.23 | 0.38 |
| MACD | -0.15 | -0.02 |
| Stochastic Oscillator | 3.06 | 15.77 |
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.